Lamivudine withdrawalFatal hepatitis B reactivation: case report

被引:0
作者
机构
关键词
Multiple Myeloma; Bone Marrow Transplant; Lamivudine; Autologous Bone Marrow; Liver Enzyme Level;
D O I
10.2165/00128415-200611080-00046
中图分类号
学科分类号
摘要
引用
收藏
页码:14 / 14
相关论文
共 50 条
[35]   Lamivudine for treating active hepatitis B in renal transplant recipients: a case report [J].
Manani, SM ;
Fabbian, F ;
Catalano, C ;
Bordin, V ;
Vogel, W ;
Di Landro, D .
CLINICAL NEPHROLOGY, 2000, 53 (04) :B44-B46
[36]   Lamivudine may prevent HBV reactivation during immunosuppressive therapy - Lamivudine therapy for prevention of immunosuppressive-induced hepatitis B virus reactivation in hepatitis B surface antigen carriers [J].
Shibolet, O ;
Ilan, Y ;
Gillis, S .
INFECTIONS IN MEDICINE, 2002, 19 (11) :536-536
[37]   Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy [J].
Ho, Edith Y. ;
Yau, Thomas ;
Rousseau, Franck ;
Heathcote, E. Jenny ;
Lau, George K. K. .
HEPATOLOGY INTERNATIONAL, 2015, 9 (02) :224-230
[38]   Preemptive adefovir versus lamivudine for prevention of hepatitis B reactivation in chronic hepatitis B patients undergoing chemotherapy [J].
Edith Y. Ho ;
Thomas Yau ;
Franck Rousseau ;
E. Jenny Heathcote ;
George K. K. Lau .
Hepatology International, 2015, 9 :224-230
[39]   Lamivudine as an alternative therapy for interferon-resistant chronic hepatitis B and the characteristics of hepatitis B virus: A case report [J].
Terui, Y ;
Saito, T ;
Watanabe, H ;
Aoki, M ;
Haga, H ;
Miyano, S ;
Takeda, T ;
Saito, K ;
Togashi, H ;
Shinzawa, H ;
Takahashi, T .
TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2000, 191 (04) :247-253